Nikon Corporation and its subsidiary Optos Plc are forming a strategic alliance with Verily Life Sciences LLC — formerly known as Google Life Sciences — to develop machine learning-enabled solutions for enhanced screenings of diabetic retinopathy and diabetic macular edema.
The partnership will reportedly combine Nikon's optical engineering and proprietary ultra-widefield technology with Verily's machine learning technology to create technology and solutions to assist physicians and others treating diabetes in screening for diabetic retinopathy and diabetic macular edema. This will, in turn, allow diabetes-treating physicians to make more efficient referrals to eyecare providers. And eyecare specialists will also be provided with assisted reading programs for easier disease diagnosis.
Click here to read the full press release.
Source: Nikon Corporation